U.S. News Room

Press Releases

Daiichi Sankyo, Inc. Adds to Its Dynamic Team, Welcoming Leigh Ann Errico as the New Vice President of Human Resources for the U.S. Commercial Group

Download the PDF version of Article

August 18, 2016

Parsippany, NJ – August 18, 2016 – Daiichi Sankyo, Inc. ("the Company") announced today that Leigh Ann Errico has joined Daiichi Sankyo, Inc. as the Company's Vice President of Human Resources for the U.S. Administrative and Commercial group. Errico brings extensive experience in change management, organizational and executive development, HR strategy for mergers and acquisitions, as well as individual and team coaching.

"I couldn't be more thrilled to welcome Leigh Ann to Daiichi Sankyo given her impressive background designing talent strategies and managing organizational initiatives that support a future-focused culture that best serves the organization, the team and the individual," said Ken Keller, President, Administrative and Commercial for Daiichi Sankyo, Inc.  "As Daiichi Sankyo continues to transform our business toward an emerging portfolio in pain relief and oncology, Leigh Ann will play a crucial role in driving growth and collaboration internally, positioning the Company and our employees for even greater levels of success."

"Daiichi Sankyo leadership has mapped out a compelling vision for the Company, and I am excited to help strategically guide and accelerate the path to reinvention during this critical stage of development," Errico said. "I am looking forward to working with colleagues to shape Daiichi Sankyo's culture, stimulate creativity, foster community, and fast-track achievement of the Company‘s overall business goals."

Prior to starting her own leadership coaching and consulting firm in 2007, Errico held roles of increasing responsibility in HR for more than 18 years, including positions at Schering Plough (since acquired by Merck) as Vice President of HR within the global pharmaceuticals division and a global leadership role on the HR team at Pharmacia (now Pfizer). In addition, Errico spent a portion of her career within financial services, telecommunications, and consumer products companies such as Merrill Lynch, AT&T, and Master Foods.

Errico holds two Master's degrees in Organizational Behavior Psychology and Corporate Communications from Fairleigh Dickinson University. She has a Bachelor of Arts degree in English and Human Resources Management from Salve Regina University. Having completed the Leadership Coaching Program at Georgetown University, Errico is also a certified Executive Coach.

About Daiichi Sankyo

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group's 2025 Vision to become a "Global Pharma Innovator with a Competitive Advantage in Oncology," Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. For more information, please visit:  Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit

Refer to

Kimberly Wix
Daiichi Sankyo, Inc.
(973) 944-2338

Back to press releases